Anna Lok, MD
University of Michigan
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
John Flaherty, PharmD
Gilead Sciences
Shared therapeutic areas:
Lawrence Friedman, MD
University of Miami
Shared therapeutic areas:
Ana Puga, MD
Children's Diagnostic & Treatment Center
Shared therapeutic areas:
Ligia Peralta, MD
University of Maryland
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Geert Robaeys, prof. dr.
Hasselt University
Shared therapeutic areas:
Novartis Pharmceuticals
Novartis Pharmaceuticals
Shared therapeutic areas:
Steven J Reynolds, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Worked with same sponsors:
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Sue Ellen Abdalian, MD
Tulane Medical Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
All 2 trials loaded